Type 2 diabetes: SGLT-2 inhibitors to be offered as first line treatment in major guidance “shake-up”

Press/Media: Expert comment

Description

BMJ News article

Period20 Aug 2025

Media contributions

1

Media contributions

  • TitleType 2 diabetes: SGLT-2 inhibitors to be offered as first line treatment in major guidance “shake-up”
    Degree of recognitionNational
    Media typePrint
    Country/TerritoryUnited Kingdom
    Date20/08/25
    DescriptionAkheel Syed, a consultant in diabetes and endocrinology and Manchester Academic Health Science Centre honorary clinical chair, told The BMJ, “For far too long, guidelines for the management of type 2 diabetes in adults have taken a glucocentric approach,” with less attention paid to “holistic prevention and treatment of cardiorenal and metabolic disease associated with diabetes.”
    Producer/AuthorKate Bowie, The BMJ
    URLhttps://doi.org/10.1136/bmj.r1777
    PersonsAkheel Syed